1174. Phase 2 STRIVE Clinical Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrates Consistent Trough Concentrations Across Diverse Patient Populations

BACKGROUND: Rezafungin is a novel echinocandin antifungal in development for treatment as well as prevention (prophylaxis) of invasive fungal infections. STRIVE (NCT02734862) is a global, randomized, double-blind, placebo-controlled, Phase 2 trial evaluating safety and efficacy of IV rezafungin once...

Descripción completa

Detalles Bibliográficos
Autores principales: Flanagan, Shawn, Rubino, Christopher M, Sandison, Taylor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776923/
http://dx.doi.org/10.1093/ofid/ofaa439.1360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776923/
http://dx.doi.org/10.1093/ofid/ofaa439.1360

Ejemplares similares